Saturday 17 October 2026
Export NVCR’s income statement to Excel — free account
NovoCure Limited
NVCR Healthcare Medical Devices
NovoCure Limited’s revenue for fiscal 2025 (year ended December 2025) was $655.4 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 63.9%, free cash flow grew 105.7% and total debt rose 100.7%, each against the same quarter a year earlier.
14.07
0.34
−2.36%
Follow NVCR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 4 | 3 |
+8 more TTM periods Free account |
| (43.22%) | (49.96%) | (38.89%) | (50.60%) | ||
| (14.56%) | (16.99%) | (13.32%) | (13.75%) | ||
ROIC |
(115.56%) | (92.52%) | (123.24%) | 0.00% | |
Return on Tangible Assets |
(28.58%) | (33.69%) | (26.04%) | (33.88%) | |
Average Days of Receivables |
76.12 | 79.24 | 82.49 | 70.88 | |
Free Cash Flow per Share |
(0.22) | (0.42) | (0.68) | (0.58) | |
Free Cash Flow |
(25.43) | (48.07) | (75.68) | (65.17) | |
Capital Expenditures |
(22.62) | (21.19) | (26.65) | (30.69) | |
| Other line items | |||||
Cash ROIC |
(2.58%) | (4.77%) | (7.62%) | (4.15%) | |
Accounts Receivable Turnover |
5.09 | 5.09 | 5.09 | 5.91 | |
Accounts Payable Turnover |
1.42 | 1.50 | 1.47 | 1.50 | |
Inventory Turnover |
4.05 | 4.03 | 4.38 | 4.05 | |
Average Days of Payables |
285.86 | 277.62 | 267.35 | 274.40 | |
Days of Inventory on Hand |
92.33 | 94.82 | 89.92 | 90.23 | |
Tax Rate |
(0.03) | (0.01) | 0.00 | 0.18 | |
Research and Development Expense of Revenue |
32.14% | 33.97% | 34.26% | 33.45% | |
Selling, General and Administrative Expense of Revenue |
66.07% | 68.41% | 63.74% | 69.43% | |
Share Based Compensation of Revenue |
18.47% | 20.51% | 16.00% | 23.01% | |
Interest Coverage |
90.29 | 22.52 | 8.76 | 6.74 | |
Operating CF/Net income |
0.02 | 0.16 | 0.36 | 0.19 | |
Depreciation/Fixed assets |
0.01 | (0.04) | (0.09) | (0.13) | |
Capex/Depreciation |
(23.71) | 5.61 | 3.09 | 2.43 | |
Revenue per Share |
6.03 | 5.91 | 5.88 | 5.74 | |
Operating CF per Share |
(0.02) | (0.24) | (0.44) | (0.31) | |
Capex per Share |
(0.19) | (0.19) | (0.24) | (0.27) | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.05 |
Columns are period end dates